Clinical trials recruiting for End-Stage Kidney Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CSL300 | 1 |
| Carvedilol | 1 |
| Conditioning and Stem cell infusion | 1 |
| Empagliflozin 25 MG | 1 |
| Metoprolol Succinate | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 5 |
| Massachusetts | 4 |
| Florida | 3 |
| Georgia | 3 |
| New York | 3 |
| North Carolina | 3 |
| Iowa | 2 |
| Minnesota | 2 |
| Mississippi | 2 |
| Nebraska | 2 |
| New Mexico | 2 |
| Pennsylvania | 2 |
Top cities
Self-screener
Recruiting trials
- CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
- Duke APOL1 Research Biorepository
- Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
- Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis
- Incremental Hemodialysis: The TwoPlus Trial
- Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
- Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)
- Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
- Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
- Symptom Monitoring in Hemodialysis
- Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
- Virtual Reality in End Stage Kidney Disease
- meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Related conditions
Trials recruiting for End-Stage Kidney Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for End-Stage Kidney Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.